See more : Cardno Limited (COLDF) Income Statement Analysis – Financial Results
Complete financial analysis of Aesther Healthcare Acquisition Corp. (AEHA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Aesther Healthcare Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Rua Bioscience Limited (RUA.NZ) Income Statement Analysis – Financial Results
- The Lakshmi Vilas Bank Limited (LAKSHVILAS.NS) Income Statement Analysis – Financial Results
- Flotek Industries, Inc. (FTK) Income Statement Analysis – Financial Results
- Shinnihonseiyaku Co., Ltd. (4931.T) Income Statement Analysis – Financial Results
- Kludein I Acquisition Corp. (INKAW) Income Statement Analysis – Financial Results
Aesther Healthcare Acquisition Corp. (AEHA)
Industry: Shell Companies
Sector: Financial Services
About Aesther Healthcare Acquisition Corp.
Aesther Healthcare Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses primarily in the pharmaceutical and medical devices sectors. The company was incorporated in 2021 and is based in New York, New York.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 33.93M | 49.00K | 35.00K |
| General & Administrative | 0.00 | 28.41M | 1.60M | 197.00K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.48M | 28.41M | 1.60M | 197.00K |
| Other Expenses | 0.00 | 1.00K | -1.00K | 0.00 |
| Operating Expenses | 2.48M | 62.35M | 1.65M | 232.00K |
| Cost & Expenses | 2.48M | 62.35M | 1.65M | 232.00K |
| Interest Income | 1.52M | 2.45K | 0.00 | 0.00 |
| Interest Expense | 691.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.52M | 236.56K | 206.30K | 171.86K |
| EBITDA | -957.74K | -564.11K | -1.65M | -232.00K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -2.48M | -62.35M | -1.65M | -232.00K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.52M | 61.78M | -1.00K | 0.00 |
| Income Before Tax | -958.43K | -62.34M | -1.65M | -232.00K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -236.56K | -206.30K | -171.86K |
| Net Income | 565.47K | -62.34M | -1.65M | -232.00K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.03 | -4.71 | -0.08 | -0.01 |
| EPS Diluted | -0.03 | -4.71 | -0.08 | -0.01 |
| Weighted Avg Shares Out | 36.50M | 13.23M | 20.20M | 20.20M |
| Weighted Avg Shares Out (Dil) | 36.50M | 13.23M | 20.20M | 20.20M |
Source: https://incomestatements.info
Category: Stock Reports